|
|
Volumn 20, Issue 2, 2006, Pages 374-376
|
|
Overexpression of phosphodiesterases in experimental autoimmune myasthenia gravis: Suppression of disease by a phosphodiesterase inhibitor
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CATHEPSIN;
CYTOKINE;
PENTOXIFYLLINE;
PHOSPHODIESTERASE;
PHOSPHODIESTERASE I;
PHOSPHODIESTERASE INHIBITOR;
PHOSPHODIESTERASE IV;
PHOSPHODIESTERASE VII;
TUMOR NECROSIS FACTOR ALPHA;
CHOLINERGIC RECEPTOR;
MESSENGER RNA;
ARTICLE;
CD4+ CD25+ T LYMPHOCYTE;
DNA MICROARRAY;
DOWN REGULATION;
DRUG ACTIVITY;
DRUG INHIBITION;
DRUG MECHANISM;
DRUG TARGETING;
ENZYME LINKED IMMUNOSORBENT ASSAY;
GENE OVEREXPRESSION;
LYMPH NODE CELL;
MYASTHENIA GRAVIS;
NONHUMAN;
PATHOGENESIS;
PRIORITY JOURNAL;
UPREGULATION;
ANIMAL;
CELL LINE;
ENZYMOLOGY;
FEMALE;
GENE EXPRESSION PROFILING;
GENE EXPRESSION REGULATION;
GENETICS;
HUMAN;
LEWIS RAT;
METABOLISM;
RAT;
REGULATORY T LYMPHOCYTE;
ANIMALS;
CATHEPSINS;
CELL LINE;
CYTOKINES;
FEMALE;
GENE EXPRESSION PROFILING;
GENE EXPRESSION REGULATION, ENZYMOLOGIC;
HUMANS;
MYASTHENIA GRAVIS;
PENTOXIFYLLINE;
PHOSPHODIESTERASE INHIBITORS;
PHOSPHORIC DIESTER HYDROLASES;
RATS;
RATS, INBRED LEW;
RECEPTORS, CHOLINERGIC;
RNA, MESSENGER;
T-LYMPHOCYTES, REGULATORY;
|
|
EID: 33644907736
PISSN: 08926638
EISSN: None
Source Type: Journal
DOI: 10.1096/fj.05-4909fje Document Type: Article |
|
Times cited : (35)
|
|
References (0)
|
